Economic evaluation of prostate cancer screening: a systematic review

被引：8
|
作者：
Lao, Chunhuan [1 ]
Brown, Charis [1 ]
Rouse, Paul [2 ]
Edlin, Richard [3 ]
Lawrenson, Ross [1 ]
机构：
[1] Univ Auckland, Hamilton, New Zealand
[2] Univ Auckland, Sch Business, Auckland 1, New Zealand
[3] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand
来源：
FUTURE ONCOLOGY | 2015年 / 11卷 / 03期
关键词：
cost; cost-effectiveness threshold; economic evaluation; prostate cancer; quality of life; screening; ASYMPTOMATIC MEN; COST; ANTIGEN; MORTALITY; PROGRAM; OVERDETECTION; POPULATION; STRATEGIES; VALUES;
D O I：
10.2217/fon.14.273
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This review, based on published papers, aims to describe the costs of prostate cancer screening and to examine whether prostate cancer screening is cost effective. The estimated cost per cancer detected ranged from Euro1299 in The Netherlands to US$44,355 in the USA. The estimated cost per life-year saved ranged from US$3000 to US$729,000, while the cost per quality-adjusted life year (QALY) was AU$291,817 and Can$371,100. The most appropriate data for economic evaluation of prostate cancer screening should be the cost per QALY gained. The estimated costs per QALY gained by prostate cancer screening were significantly higher than the cost-effectiveness threshold, suggesting that even when based on favorable randomized controlled trials in younger age groups, prostate cancer screening is still not cost effective.
引用
收藏
页码：467 / 477
页数：11
相关论文
共 50 条
  • [31] Economic evaluation of a prostate cancer screening program in France: a decision model
    Perez-Niddam, K
    Thoral, F
    Charvet-Protat, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 32 (02) : 167 - 173
  • [32] Intensity-Modulated Radiotherapy for the Treatment of Prostate Cancer: A Systematic Review and Economic Evaluation Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2011, 186 (02): : 534 - 535
  • [33] Is Prostate-Specific Antigen Effective for Population Screening of Prostate Cancer? A Systematic Review
    Lee, Yoon Jae
    Park, Ji Eun
    Jeon, Byung Ryul
    Lee, Sang Moo
    Kim, Soo Young
    Lee, You Kyoung
    ANNALS OF LABORATORY MEDICINE, 2013, 33 (04) : 233 - 241
  • [34] Men's willingness to pay for prostate cancer screening: a systematic review
    Farabi, Hiro
    Rezapour, Aziz
    Moradi, Najmeh
    Aghamir, Seyed Mohammad Kazem
    Koohpayehzadeh, Jalil
    SYSTEMATIC REVIEWS, 2020, 9 (01)
  • [35] FACTORS THAT INFLUENCE PROSTATE CANCER SCREENING IN HISPANIC MEN: A SYSTEMATIC REVIEW
    Martinez, Jacob
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S498 - S498
  • [36] Men’s willingness to pay for prostate cancer screening: a systematic review
    Hiro Farabi
    Aziz Rezapour
    Najmeh Moradi
    Seyed Mohammad Kazem Aghamir
    Jalil Koohpayehzadeh
    Systematic Reviews, 9
  • [37] Economic evaluation of newborn screening for congenital cytomegalovirus infection: A systematic review
    Saito, Hiroki
    Sakai, Kotomi
    Tanaka, Motoko
    Konomura, Keiko
    Suzuki, Mitsuyoshi
    Tajima, Go
    Hoshino, Eri
    EUROPEAN JOURNAL OF PEDIATRICS, 2025, 184 (01)
  • [38] Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review
    Olena Mandrik
    Anne I. Hahn
    James W. F. Catto
    Ann G. Zauber
    Marcus Cumberbatch
    James Chilcott
    PharmacoEconomics, 2023, 41 : 633 - 650
  • [39] Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review
    Mandrik, Olena
    Hahn, Anne I.
    Catto, James W. F.
    Zauber, Ann G.
    Cumberbatch, Marcus
    Chilcott, James
    PHARMACOECONOMICS, 2023, 41 (06) : 633 - 650
  • [40] A SCOPING REVIEW OF ECONOMIC EVALUATION OF BREAST CANCER SCREENING IN CHINA
    Jiang, J.
    Jiang, S.
    Ahumada-Canale, A.
    Chen, Z.
    Si, L.
    Jiang, Y.
    Yang, L.
    Gu, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S407 - S407
12345